This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_CERVIX_ADENO_EXALLC for full statistics.
Adenocarcinomas of cervix
C3_CERVIX_ADENO
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule
Sex
only females
219462
Check conditions None
219462
Check pre-conditions, main-only, mode, registry filters
Cancer registry: Topography ICD-O-3
C53
Cancer registry: Morphology ICD-O-3
8140
Cancer registry: Behaviour codes
3
1 out of 7 registries used, show all original rules.
116
Check minimum number of events None
116
Include endpoints None
116
Remove individuals based on genotype QC
112
C3_CERVIX_ADENO
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF8
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Adenocarcinomas of cervix
based on the number of shared cases.
Broader endpoints:
- Adenocarcinomas of cervix (controls excluding all cancers)
- Malignant neoplasm of cervix uteri (controls excluding all cancers)
- Malignant neoplasm of cervix uteri
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 112 | 112 | - |
| Unadjusted prevalence (%) | 0.03 | 0.05 | - |
| Mean age at first event (years) | 47.54 | 47.54 | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_CERVIX_ADENO – Adenocarcinomas of cervix
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Adenocarcinomas of cervix
↥Endpoint not on priority list, no data to show.